#65 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians need this information because patients may not perceive cannabis as risky despite evidence linking use to anxiety, depression, and psychosis, creating a gap between patient beliefs and clinical reality that affects treatment discussions and compliance. This awareness gap suggests clinicians should proactively educate patients about mental health risks rather than assuming they already understand them, particularly in states with legalized cannabis where normalization may increase use. Public misunderstanding of cannabis-mental health connections means clinicians must strengthen screening and counseling practices to identify at-risk patients and prevent adverse psychiatric outcomes.
A Massachusetts survey revealed that the majority of state residents lack awareness of the mental health risks associated with cannabis use, particularly regarding conditions such as anxiety, depression, and psychosis. This knowledge gap is clinically significant given that cannabis is increasingly accessible through legal dispensaries and patients may not understand dose-related psychiatric adverse effects or risks in vulnerable populations such as adolescents and those with personal or family histories of mental illness. The findings underscore an important gap between public perception and clinical evidence, where many patients may not spontaneously report cannabis use or associate their emerging psychiatric symptoms with cannabis exposure during clinical encounters. For clinicians in Massachusetts and similar jurisdictions where cannabis is legal and widely available, this limited public awareness necessitates proactive screening for cannabis use and explicit patient education about potential mental health consequences. Physicians should routinely counsel patients about psychiatric risks, screen for mood and anxiety disorders in regular cannabis users, and discuss safer alternatives for symptom management. The practical takeaway is that clinicians cannot rely on patient knowledge of cannabis risks and must incorporate detailed cannabis history-taking and mental health risk counseling into standard practice, particularly for younger patients and those with psychiatric vulnerability factors.
“What we’re seeing in Massachusetts reflects a national gap in patient education that I encounter regularly in my practice: people are using cannabis without understanding that regular use, particularly in adolescents and those with genetic vulnerability to psychosis, carries real psychiatric risks that shouldn’t be minimized just because the substance is legal. The legalization movement has been so focused on access and social justice that we’ve largely abdicated our responsibility as physicians to have honest conversations about who should and shouldn’t be using cannabis, and under what circumstances.”
? Although public awareness campaigns have increased in many states, this Massachusetts survey highlights a persistent gap between available evidence and community knowledge regarding cannabis and mental health risks, particularly concerning psychosis, anxiety exacerbation, and cognitive effects in adolescents and young adults. The survey’s cross-sectional design cannot establish causation or determine which populations are most misinformed, and awareness itself does not necessarily change behavior or clinical outcomes. Importantly, risk perception varies considerably based on product type (flower versus concentrated forms), individual genetic vulnerability, and baseline psychiatric history, factors that patients often cannot self-assess without professional guidance. Clinicians should proactively screen for cannabis use and educate patients about dose-dependent mental health risks during preventive visits, particularly those with personal or family histories of psychosis or mood disorders, while recognizing that many patients may arrive with incomplete or inaccurate information about safety.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
